A difficult-to-treat pleuropulmonary histoplasmosis in a patient with rheumatoid arthritis in Taiwan
Amphotericin B and itraconazole are the primary agents for treating histoplasmosis. Newer azoles are alternatives for patients refractory to or intolerant of standard therapy. We report an 83-year-old woman with rheumatoid arthritis complicated with pleuropulmonary histoplasmosis who responded to li...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2023-02-01
|
| シリーズ: | Journal of Microbiology, Immunology and Infection |
| 主題: | |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S1684118222002869 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|